HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.

Abstract
Effects of a new cholecystokinin (CCK)A-receptor antagonist, T-0632 [sodium (S)-1-(2-fluorophenyl)-2, 3-dihydro-3-[(3-isoquinolinylcarbonyl) amino]-6-methoxy-2-oxo-1H-indole-3-propanoate], on caerulein-induced and pancreatic duct ligation-induced pancreatitis models were studied and compared with the CCKA-receptor antagonist loxiglumide and the orally active protease inhibitor camostate, respectively. In rats, orally administered T-0632 potently prevented the caerulein-induced increases in pancreatic digestive enzymes in plasma and suppressed the histological changes in the pancreas. The estimated ED50 values of T-0632 and loxiglumide were 0.0092 and 8.9 mg/kg, respectively. In dogs, T-0632 (0.1, 1 mg/kg, i.d.) prevented the caerulein-induced increase in plasma amylase activity in a dose-dependent manner. Loxiglumide (100 mg/kg, i.d.) did not show any preventive effects. In pancreatic duct ligation (6 hr)-induced pancreatitis of the rat, T-0632 (0.001-0.1 mg/kg, p.o.) partially prevented both the increase in plasma amylase activity and the histological changes in the pancreas, whereas camostate (10, 100 mg/kg, p.o.) did not show any preventive effects. In pancreatic duct ligation (3 hr)-induced pancreatitis, caerulein injection (1 microgram/kg, s.c.) caused a further increase in plasma amylase activity, and T-0632 (0.01, 0.1 mg/kg, p.o.) dose-dependently decreased the aggravation by caerulein. We conclude that T-0632 showed preventive effects on all of these pancreatitis models by oral or intraduodenal administration. These results suggest that CCK plays an important role in progression and aggravation of acute pancreatitis, and T-0632 may have a therapeutic value in these disease states.
AuthorsH Taniguchi, E Yomota, E Kume, T Shikano, T Endo, M Nagasaki
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 73 Issue 2 Pg. 105-12 (Feb 1997) ISSN: 0021-5198 [Print] Japan
PMID9074944 (Publication Type: Journal Article)
Chemical References
  • Esters
  • Guanidines
  • Hormone Antagonists
  • Indoles
  • Protease Inhibitors
  • Receptor, Cholecystokinin A
  • Receptors, Cholecystokinin
  • camostat
  • T 0632
  • Gabexate
  • loxiglumide
  • Ceruletide
  • Amylases
  • Proglumide
Topics
  • Acute Disease
  • Amylases (blood)
  • Animals
  • Ceruletide
  • Disease Models, Animal
  • Dogs
  • Esters
  • Female
  • Gabexate (analogs & derivatives)
  • Guanidines (pharmacology)
  • Hormone Antagonists (pharmacology)
  • Indoles (pharmacology)
  • Ligation
  • Male
  • Pancreatic Ducts (surgery)
  • Pancreatitis (chemically induced, drug therapy, etiology)
  • Proglumide (analogs & derivatives, pharmacology)
  • Protease Inhibitors (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Receptor, Cholecystokinin A
  • Receptors, Cholecystokinin (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: